DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation

A minority of cancers have breast cancer gene (BRCA) mutations that confer sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors (PARPis), but the role for PARPis in BRCA-proficient cancers is not well established. This suggests the need for novel combination therapies to expand the use of t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Proc Natl Acad Sci U S A
Päätekijät: Abbotts, Rachel, Topper, Michael J., Biondi, Christopher, Fontaine, Daniel, Goswami, Reena, Stojanovic, Lora, Choi, Eun Yong, McLaughlin, Lena, Kogan, Aksinija A., Xia, Limin, Lapidus, Rena, Mahmood, Javed, Baylin, Stephen B., Rassool, Feyruz V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: National Academy of Sciences 2019
Aiheet:
Biological Sciences
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842607/
https://ncbi.nlm.nih.gov/pubmed/31591209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1903765116
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia